Testing a new lab method for GABABR antibody encephalitis
Part of Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This study is testing a new lab test that may help doctors more accurately diagnose GABABR antibody encephalitis, a type of brain inflammation. The test looks for certain antibodies in your blood or spinal fluid.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 14 and 85 years old.
- You have symptoms like memory problems, seizures, or psychiatric symptoms that started within the last 3 months.
- You are willing to provide a blood and/or spinal fluid sample for testing.
- You are living in the area and willing to come for follow-up visits.
- You must not have any other disease that could explain your symptoms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study looks for new markers in the blood of people with autoimmune encephalitis (a condition where the immune system attacks the brain). It aims to better understand what causes the disease and find new ways to diagnose it.
This study tests a new medicine (ART5803) in people whose immune system attacks a brain receptor called NMDAR, causing encephalitis (brain swelling) or psychiatric symptoms. It aims to see if the medicine can reduce symptoms like confusion, memory problems, or psychosis.
This study tests a natural bile-derived medicine (Calcus Bovis Sativus) to see if it can help adults with new or recent brain inflammation (encephalitis). It focuses on people whose encephalitis is caused by the immune system or a virus, and who have not fully recovered.
This study collects health information from people with autoimmune encephalitis, a condition where the body's immune system attacks the brain. It aims to understand the disease better, and if you have seizures from it, you can join a special epilepsy part.
This Phase 2 study tests inebilizumab in people with NMDA receptor encephalitis, an immune-related brain condition. It looks to see if adding this treatment after starting steroids (and possibly other first treatments) improves recovery and safety.
This study looks at how the immune system works in certain neurological conditions, including autoimmune encephalitis and related nerve disorders. Researchers may use blood and/or spinal fluid samples, especially when antibodies are present or can’t be found, to better understand what’s driving the illness.
Hear when a new Autoimmune Encephalitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.